T. Rowe Price Associates
CEMI

T. Rowe Price Associates’s Chembio diagnostics, Inc. CEMI Stock Holding History

T. Rowe Price Associates’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-15,200
Closed -$17K – 3077
2021
Q4 		$17K Hold
15,200
– – ﹤0.01% 2965
2021
Q3 		$38K Hold
15,200
– – ﹤0.01% 2915
2021
Q2 		$45K Sell
15,200
-29,924
-66% -$104K ﹤0.01% 2904
2021
Q1 		$158K Buy
45,124
+6,521
+17% +$36.3K ﹤0.01% 2735
2020
Q4 		$183K Sell
38,603
-19,300
-33% -$99.7K ﹤0.01% 2570
2020
Q3 		$281K Buy
+57,903
New +$274K ﹤0.01% 2313

Other funds holding CEMI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EGM
Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates's CEMI Position: Q1 2022 in Review

T. Rowe Price Associates sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2022, closing a stake of 15,200 shares — an estimated $17K sold.

T. Rowe Price Associates first reported a position in CEMI in Q3 2020 and held it in 6 quarters. The position peaked at $281K in Q3 2020. 36 funds tracked by Wall St. Rank hold CEMI as of Q1 2022.

  • T. Rowe Price Associates reported no remaining Chembio diagnostics, Inc. position as of Q1 2022 after selling out during the quarter.
  • T. Rowe Price Associates sold 15,200 Chembio diagnostics, Inc. shares in Q1 2022, an estimated $17K.
  • T. Rowe Price Associates first reported a position in Chembio diagnostics, Inc. in Q3 2020 and held it in 6 quarters.
  • T. Rowe Price Associates's Chembio diagnostics, Inc. position peaked at $281K in Q3 2020.
  • 36 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2022.

Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.